NR1H4 and metabolic dysfunction-associated steatotic liver disease: FXR, functioning as a pivotal nuclear receptor governing lipid metabolism [9], can inhibit hepatic fatty acid synthesis, accordingly lowering liver TG levels, alleviating hepatic lipid accumulation, and subsequently mitigating the development of NAFLD [10,11].